Evidence map›Paper›PMID 33981712›Full record

ArticleFrontiers in medicine2021

Outcomes of Sepsis and Septic Shock in Cancer Patients: Focus on Lactate.

René López, Rodrigo Pérez-Araos, Fernanda Baus, Camila Moscoso, Álvaro Salazar, Jerónimo Graf, José Miguel Montes, Suraj Samtani

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Shadow-Calibrated Stereo Vision for Colorimetric Sweat Analysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Prognostic Factors and Risk Stratification in Malignant Tumor Patients With Sepsis: A Retrospective Cohort Study.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

René LópezDepartamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.
Rodrigo Pérez-AraosDepartamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.
Fernanda BausEscuela de Kinesiología, Facultad de Medicina Clínica Alemana - Universidad del Desarrollo, Santiago, Chile.
Camila MoscosoDepartamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.
Álvaro SalazarDepartamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.
Jerónimo GrafDepartamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.
José Miguel MontesDepartamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.
Suraj SamtaniDepartamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.
Clínica Alemana · CLUniversidad del Desarrollo · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of oncological patients (OP) admitted to intensive care units (ICU) for sepsis/septic shock has dramatically increased in recent years. The definition of septic shock has been modified, adding hyperlactatemia as a severity biomarker for mortality. However, it remains poorly reported in septic OP. We performed a retrospective analysis from a prospective database of sepsis/septic shock patients admitted to our ICU between September 2017 and September 2019 and followed until day 90. We identified 251 patients and 31.9% had active oncological comorbidity, mainly solid tumor (81.3%). Septic shock criteria were met for 112 (44.6%). Hyperlactatemia was observed in 136 (54.2%) patients and this was associated with a lower survival rate. Overall 90-day mortality was 15.1%. In OP vs. non-OP, hyperlactatemia was more frequent (65% vs. 49.1%,

Indexed as

cancercancer prevention and controlintensive care unitoncological patientseptic shock

Identifiers

PMID33981712
PMCPMC8107210
OpenAlexW3162250766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.